mds: the role of the multidisciplinary team
Published 2 years ago • 50 plays • Length 0:35Download video MP4
Download video MP3
Similar videos
-
0:55
the role of rna modifications in mds and aml
-
3:01
the role of piez01 variants in patients with mds
-
1:41
an overview of the mds diagnosis pathway
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
2:23
benefits, applicability & uses of the ipss-m in mds
-
1:16
state of the art: mds
-
3:22
what is "mds"? (myelodysplastic syndromes)
-
4:57
diagnosis of myelodysplastic syndromes (mds)
-
6:36
mds: low-risk disease treatment options
-
1:02
mpn disease biology: jak2.v617f causes lymphopenia by blocking lymphopoiesis
-
2:34
the role of ezh2 mutations in mds
-
1:17
exciting novel treatments being developed for mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:21
hmas for mds- a party of one
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:18
key recurrent mutations in mds
-
1:04
the future of mds management
-
1:30
the prognostic value of patient-reported outcomes in mds
-
1:19
the promise of precision medicine in mds
-
1:55
mds genomics: diagnosis and prognosis
-
1:17
phase ii study of tosedostat in mds